NONPRESCRIPTION DRUGS ADVISORY COMMITTEE AND
ARTHRITIS ADVISORY COMMITTEE
July 20, 1999
FLEXERIL MR
NDA 21070
MERCK BACKGROUNDER
Part I (Guide to Reader, Table of Contents, Pages 1-62)
Part II (Pages 63 – Appendix I)
FDA Backgrounder Materials
Attachment A to Executive Summary
Medical Officer Review, HFD-550
Safety Review, Medical Officer Review, HFD-560
Attachment 1 to the Safety Review
Attachment II to the Safety Review
Attachment III Part 1 to the Safety Review
Attachment III Part 2 to the Safety Review
Pharmacokinetic Review (Clinical Pharmacology/ Biopharmaceutics Review)